FDA Issues Warnings to Marketers of Unapproved “Chelation” Products

On October 14, 2010, FDA warned eight companies that market over-the-counter chelation products that these are unapproved drugs and devices and that it is a violation of federal law to make false claims about the products.

Source: http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm228685.htm

supplier Docetaxel Docetaxel clinical trial Docetaxel structure

European Mistletoe

This fact sheet provides basic information about the herb European mistletoe—common names, uses, potential side effects, and resources for more information. European mistletoe is a semiparasitic plant that grows on several types of trees in temperate regions worldwide. Where the term "mistletoe" is used in this fact sheet, it refers to European mistletoe. (European mistletoe is different from American mistletoe, which is used as a holiday decoration.)

What Mistletoe Is Used For

  • Mistletoe has been used for centuries in traditional medicine to treat seizures, headaches, and other conditions.
  • Mistletoe is used mainly in Europe as a treatment for cancer.

Source: http://nccam.nih.gov/health/mistletoe/ataglance.htm?nav=rss

Docetaxel solubility

Director’s Message on the Flu

As we are all aware, flu season is upon us. In a typical year, approximately 5 to 20 percent of the population gets the seasonal flu and approximately 36,000 flu-related deaths are reported. This year, we are faced with not only the seasonal flu, but also the novel H1N1 flu virus. This additional virus may cause a more dangerous flu season with more people getting sick, being hospitalized and dying than during a regular flu season. Like seasonal flu, illness in people with H1N1 can vary from mild to severe.

Source: http://nccam.nih.gov/about/offices/od/director.htm?nav=rss

See here Look at here More information

FY 2008 Budget Request

On June 22, Ruth L. Kirschstein, M.D., Acting Director NCCAM, presented the President’s Fiscal Year (FY) 2008 budget request of $121,699,000 for the National Center for Complementary and Alternative Medicine NCCAM) to the Senate Subcommittee on Labor-HHS-Education Appropriations.

Source: http://nccam.nih.gov/about/offices/od/directortestimony/0607.htm?nav=rss

Sirolimus structure Sirolimus solubility Sirolimus molecular weight

In the News: Study Shows Vitamin E Supplements Increase Incidence of Prostate Cancer

An updated analysis of data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) showed that vitamin E supplements significantly increased the incidence of prostate cancer in healthy men. At a median followup of 7 years, the researchers observed that the incidence of prostate cancer was increased by 17 percent in men who received the vitamin E supplement alone compared with those who received placebo. The findings were recently published in the Journal of the American Medical Association.

Source: http://nccam.nih.gov/news/2011/101111.htm?nav=rss

Docetaxel molecular weight Docetaxel price Docetaxel ic50

Omega?3 Fatty Acids May Reduce Inflammation and Anxiety in Healthy Young Adults

A new study has provided the first evidence that omega‑3 fatty acids of the types found in fish oils may reduce anxiety in healthy people who have not been diagnosed with an anxiety disorder. Omega‑3 fatty acids also reduced inflammation in the study participants but did not affect depressive symptoms.

Source: http://nccam.nih.gov/research/results/spotlight/072811.htm?nav=rss

See here Look at here More information

February Is American Heart Month

Heart disease is the leading cause of death in the United States and is a major cause of disability. NCCAM has funded many basic and clinical studies related to heart disease. To ensure safe and coordinated care, people should talk to their health care providers about any CAM therapy that they are currently using or considering.

Source: http://nccam.nih.gov/news/thismonth/february08.htm?nav=rss

Docetaxel Taxotere Docetaxel Microtubule Formation inhibitor Docetaxel 114977-28-5

Managing Low-Back Pain: An Evidence-Based Approach for Primary Care Physicians

A physicians response to a patient with low-back pain (LBP) should take into account psychological and social factors as well as physical symptoms, according to an article published in The Journal of Family Practice. The article looks at two case studies in light of evidence-based clinical guidelines developed by Roger Chou et al. for the American Pain Society and the American College of Physicians. The articles authors, whose work was funded in part by NCCAM, recommend a measured approach to the use of imaging (x-rays and MRI/CT scans) and medication.

Source: http://nccam.nih.gov/research/results/spotlight/040209.htm?nav=rss

Docetaxel Microtubule Formation inhibitor Docetaxel 114977-28-5 buy Docetaxel

April 7 Council Meeting Public Conference

Teleconference

April 7, 2009

1:00 P.M.1:15 P.M. EST

877-719-9799 (toll-free); Passcode: 6064250

The first 15 minutes of the teleconference will be monitored by the Premiere Conferencing Operator. People who are calling on this line just listen only when Dr. Briggs speaks. This line will be closed at 1:15 P.M. EST.

Source: http://nccam.nih.gov/about/naccam/?nav=rss

Sirolimus solubility

FDA Warning: Dietary Supplements Used for Sexual Enhancement

FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement

The U.S. Food and Drug Administration (FDA)
is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON.
These products are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, but they are in fact illegal drugs that contain potentially harmful undeclared ingredients.
These products have not been approved by FDA, and there is no guarantee of their safety and effectiveness, or of the purity of their ingredients.

FDA advises consumers who have used any of these products to discontinue use and to consult their health care provider.
FDA encourages anyone experiencing ED to seek guidance from a health care provider before purchasing a product to treat this medical condition.

"These products threaten the public health because they contain undeclared chemicals that are similar or identical to the active ingredients used in several FDA-approved prescription drug products.
This risk is even more serious because consumers may not know that these ingredients can interact with medications and dangerously lower their blood pressure," said Dr. Steven Galson, Director of FDA’s Center for Drug Evaluation and Research.

Source: http://nccam.nih.gov/news/alerts/index.htm?nav=rss

supplier Sirolimus price Sirolimus Sirolimus clinical trial